Abstract
Background and Objectives
Methods
Results
Conclusion
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Clinical EpidemiologyReferences
- The ecosystem of health decision making: from fragmentation to synergy.Lancet Public Health. 2022; 7: e378-e390
- Selection of essential medicines at country level: Using the WHO model list of essential medicines to update a national essential medicines list, ed. World Health Organization..Medicines Selection, IP and Affordability Team, WHO Headquarters, Geneva, Switzerland2020
- Essential medicines are more available than other medicines around the Globe.PLoS One. 2014; 9: e87576
- Essential medicines for universal health coverage.Lancet. 2017; 389: 403-476
- Evaluating the quality and use of economic data in decisions about essential medicines.Bull World Health Organ. 2015; 93: 693-699
- Essential medicines are still essential.Lancet. 2015; 386: 1601-1603
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines.BMJ. 2016; 353: i2089
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.BMJ. 2016; 353: i2016
- GRADE evidence to decision (EtD) framework for coverage decisions.Int J Technol Assess Health Care. 2017; 33: 176-182
- WHO medicines strategy: Revised procedure for updating WHO’s Model List of Essential Drug. World Health Organization, Geneva, Switzerland2001
- The “square box”: therapeutic Equivalence as a Foundation of the WHO model List of essential medicines.Front Pharmacol. 2020; 11: 578000
- The composition of WHO’s expert committee on essential medicines needs more scrutiny.BMJ. 2014; 349: g5211
- Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.Int J Qual Health Care. 2007; 19: 349-357
- The GRADE Evidence to Decision (EtD) framework for health system and public health decisions.Health Res Policy Syst. 2018; 16: 45
- GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT.J Clin Epidemiol. 2017; 81: 101-110
- Qualitative analysis of content.Appl Soc Res Methods Quest Inf Libr Sci. 2009; 308: 319
- Interpretive description: Qualitative research for applied practice.Routledge, 2016
- Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets.Global Health. 2010; 6: 9
- Comparison of essential medicines lists in 137 countries.Bull World Health Organ. 2019; 97: 394-404C
- Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.BMJ Open. 2022; 12: e053349
- Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment.Health Qual Life Outcomes. 2017; 15: 183
- GRADE Evidence to Decision Frameworks for adoption, adaptation and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT.J Clin Epidemiol. 2016; 81: 101-110
Article info
Publication history
Footnotes
Declaration of interest: Thomas Piggott: Member of the GRADE Working Group. Lorenzo Moja: Staff member of the Secretariat of the Expert Committee on the Selection and Use of Essential Medicines and an employee of the WHO, Geneva, Switzerland. Elie A. Akl: Member of the GRADE Working Group. John Lavis: Declared none. Graham Cooke: was the chair of the 2019 and 2021 EML Expert Committee. He is supported in part by the Imperial NIHR Biomedical Research Centre. Tamara Kredo: Member of the GRADE Working Group, Co-director of South African GRADE Network and member South African Essential Medicines List Committee. Hans Hogerzeil: Was secretary of the WHO Expert Committee from 1999 to 2007 and Director of WHO's Essential Medicines Department from 2003 to 2011. He declares unrelated consultancy work for WHO, the Access to Medicine Index, Health Action International, and Management Sciences for Health. Benedikt Huttner: Staff member of the Secretariat of the Expert Committee on the Selection and Use of Essential Medicines and an employee of the WHO, Geneva, Switzerland. Pablo Alonso-Coello: Member of the GRADE Working Group, Director Barcelona GRADE Center. Holger Schünemann: Member and co-chair of the GRADE Working Group, Director Cochrane Canada and McGRADE Centre.
Author Contributions: Thomas Piggott: Conceptualization; Data curation; Formal analysis; Investigation; Methodology; Project administration; Resources; Software; Validation; Visualization; Roles/Writing–original draft; Writing–review & editing. Lorenzo Moja: Conceptualization; Formal analysis; Investigation; Methodology; Validation; Roles/Writing–original draft; Writing–review & editing. Elie Akl: Formal analysis; Investigation; Methodology; Validation; Writing–review & editing. John Lavis: Formal analysis; Investigation; Methodology; Validation; Writing–review & editing. Graham Cooke: Investigation; Methodology; Validation; Writing–review & editing. Tamara Kredo: Investigation; Validation; Writing–review & editing. Hans Hogerzeil: Investigation; Validation; Writing–review & editing. Benedikt Huttner: Investigation; Validation; Writing–review & editing. Pablo Alonso-Coello: Investigation; Validation; Writing–review & editing. Holger J. Schünemann: Conceptualization; Formal analysis; Investigation; Methodology; Project administration; Resources; Supervision; Validation; Visualization; Roles/Writing–original draft; Writing–review & editing.
